Literature DB >> 17510413

Ras transformation of RIE-1 cells activates cap-independent translation of ornithine decarboxylase: regulation by the Raf/MEK/ERK and phosphatidylinositol 3-kinase pathways.

Sofia Origanti1, Lisa M Shantz.   

Abstract

Ornithine decarboxylase (ODC) is the first and generally rate-limiting enzyme in polyamine biosynthesis. Deregulation of ODC is critical for oncogenic growth, and ODC is a target of Ras. These experiments examine translational regulation of ODC in RIE-1 cells, comparing untransformed cells with those transformed by an activated Ras12V mutant. Analysis of the ODC 5' untranslated region (5'UTR) revealed four splice variants with the presence or absence of two intronic sequences. All four 5'UTR species were found in both cell lines; however, variants containing intronic sequences were more abundant in Ras-transformed cells. All splice variants support internal ribosome entry site (IRES)-mediated translation, and IRES activity is markedly elevated in cells transformed by Ras. Inhibition of Ras effector targets indicated that the ODC IRES element is regulated by the phosphorylation status of the translation factor eIF4E. Dephosphorylation of eIF4E by inhibition of mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK) or the eIF4E kinase Mnk1/2 increases ODC IRES activity in both cell lines. When both the Raf/MEK/ERK and phosphatidylinositol 3-kinase/mammalian target of rapamycin pathways are inhibited in normal cells, ODC IRES activity is very low and cells arrest in G(1). When these pathways are inhibited in Ras-transformed cells, cell cycle arrest does not occur and ODC IRES activity increases, helping to maintain high ODC activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510413     DOI: 10.1158/0008-5472.CAN-06-4627

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Ornithine decarboxylase mRNA is stabilized in an mTORC1-dependent manner in Ras-transformed cells.

Authors:  Sofia Origanti; Shannon L Nowotarski; Theresa D Carr; Suzanne Sass-Kuhn; Lan Xiao; Jian-Ying Wang; Lisa M Shantz
Journal:  Biochem J       Date:  2012-02-15       Impact factor: 3.857

Review 2.  Polyamines in mammalian pathophysiology.

Authors:  Francisca Sánchez-Jiménez; Miguel Ángel Medina; Lorena Villalobos-Rueda; José Luis Urdiales
Journal:  Cell Mol Life Sci       Date:  2019-06-21       Impact factor: 9.261

Review 3.  Mammalian polyamine metabolism and function.

Authors:  Anthony E Pegg
Journal:  IUBMB Life       Date:  2009-09       Impact factor: 3.885

Review 4.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

5.  Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development.

Authors:  Takeshi Ueda; Masato Sasaki; Andrew J Elia; Iok In Christine Chio; Koichi Hamada; Rikiro Fukunaga; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

6.  Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model.

Authors:  Shannon L Nowotarski; Lisa M Shantz
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

7.  Knockout of Raptor destabilizes ornithine decarboxylase mRNA and decreases binding of HuR to the ODC transcript in cells exposed to ultraviolet-B irradiation.

Authors:  Shannon L Nowotarski; Robert P Feehan; Christopher Presloid; Lisa M Shantz
Journal:  Biochem Biophys Res Commun       Date:  2018-10-09       Impact factor: 3.575

8.  Regulation of eukaryotic translation initiation factor 6 dynamics through multisite phosphorylation by GSK3.

Authors:  Courtney F Jungers; Jonah M Elliff; Daniela S Masson-Meyers; Christopher J Phiel; Sofia Origanti
Journal:  J Biol Chem       Date:  2020-07-23       Impact factor: 5.157

9.  Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.

Authors:  Eric T Alexander; Kelsey Mariner; Julia Donnelly; Otto Phanstiel; Susan K Gilmour
Journal:  Mol Cancer Ther       Date:  2020-08-03       Impact factor: 6.261

10.  Romidepsin inhibits Ras-dependent growth transformation of NIH 3T3 fibroblasts and RIE-1 epithelial cells independently of Ras signaling inhibition.

Authors:  Ariella B Hanker; Kevin D Healy; Jean Nichols; Channing J Der
Journal:  J Mol Signal       Date:  2009-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.